Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COMMUNITY HEALTH SYSTEMS INCCYH · Entity 5628 | Division President | March 01, 2019 | March 04, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COMMUNITY HEALTH SYSTEMS INC
Report date March 01, 2019 · Filed March 04, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 66,025 |
Reported balance
After 2019-03-01 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2019-03-01 · Grant · Acquired 22,500 · Balance 66,025 F1: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. |
| Common StockSEC Table I · non-derivative | Direct | 62,969 |
Reported balance
After 2019-03-01 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2019-03-01 · Tax withholding · Disposed 3,329 · Balance 62,969 |
| Performance Based RestrictedSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 45,000 |
Reported balance
After 2019-03-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-03-01 · Grant · Acquired 45,000 · Balance 45,000 F2: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2019-2021 Performance Period. |
| Performance Based RestrictedSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 30,000 |
Reported balance
Holding disclosure · report date 2019-03-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 30,000 F4: The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2018-2020 Performance Period. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.99 · Expires 2029-02-28 | Direct | 22,500 |
Reported balance
After 2019-03-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-03-01 · Grant · Acquired 22,500 · Balance 22,500 F3: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
F2: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2019-2021 Performance Period.
F3: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.
F4: The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2018-2020 Performance Period.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2019 Filed Mar 4, 2019 21:20 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantStock Options (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $4.99 | $0.00 |
DisclosureSEC source: 0001209191-19-015589 · doc4.xml · derivative · entry 4 Ramsey Beryl · CIK 0001730465 · Division President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2029-02-28 F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 21:20 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantPerformance Based Restricted · Derivative | 45,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-015589 · doc4.xml · derivative · entry 3 Ramsey Beryl · CIK 0001730465 · Division President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires not disclosed F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2019-2021 Performance Period. F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2019-2021 Performance Period. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 21:20 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Tax withholdingCommon Stock | 3,329 | $4.99 | $16,611.71 |
DisclosureSEC source: 0001209191-19-015589 · doc4.xml · nonDerivative · entry 2 Ramsey Beryl · CIK 0001730465 · Division President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,969 Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 21:20 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantCommon Stock | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-015589 · doc4.xml · nonDerivative · entry 1 Ramsey Beryl · CIK 0001730465 · Division President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,025 F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| October 01, 2018 Filed Oct 1, 2018 21:45 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Tax withholdingCommon Stock | 406 | $3.21 | $1,303.26 |
DisclosureSEC source: 0001209191-18-052865 · doc4.xml · nonDerivative · entry 1 Ramsey Beryl · CIK 0001730465 · Division President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,525 Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:40 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantPerformance Based Restricted · Derivative | 30,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015691 · doc4.xml · derivative · entry 3 Ramsey Beryl · CIK 0001730465 · Division President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2028-02-28 F2 · derivative.exercise_date: The vesting of 50% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Same-Store Adjusted EBITDA Growth between January 1, 2018 and December 31, 2020 (the "2018-2020 Performance Period"). The vesting of the remaining 50% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Same-Store Adjusted EBITDA Margin Improvement for the 2018-2020 Performance Period. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the target number of performance-based restricted shares subject to the attainment of the Cumulative Same-Store Adjusted EBITDA Growth and Cumulative Same-Store Adjusted EBITDA Margin Improvement criteria, as applicable, will ultimately vest on the third anniversary of the date of grant, with the vesting percentage to be determined based upon achievement with respect to the Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:40 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Tax withholdingCommon Stock | 892 | $4.58 | $4,085.36 |
DisclosureSEC source: 0001209191-18-015691 · doc4.xml · nonDerivative · entry 2 Ramsey Beryl · CIK 0001730465 · Division President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,931 Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:40 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015691 · doc4.xml · nonDerivative · entry 1 Ramsey Beryl · CIK 0001730465 · Division President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,823 F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2018 Filed Oct 1, 2018 21:45 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantPerformance Based Restricted · Derivative | 30,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052865 · doc4.xml · derivative · entry 2 Ramsey Beryl · CIK 0001730465 · Division President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2028-02-28 F1 · derivative.exercise_date: The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between January 1, 2018 and December 31, 2020 (the "2018-2020 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the target number of performance-based restricted shares subject to the attainment of the applicable performance measures will ultimately vest on the third anniversary of the date of grant, with the vesting percentage to be determined based upon achievement with respect to the applicable criteria during the 2018-2020 Performance Period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.